K111914 · Olympus America Inc. / Scientific Equipment Group · OEO · Aug 21, 2012 · Hematology
Device Facts
Record ID
K111914
Device Name
VIRTUAL SLIDE SYSTEM, OLYMPUS VS800 SYSTEM
Applicant
Olympus America Inc. / Scientific Equipment Group
Product Code
OEO · Hematology
Decision Date
Aug 21, 2012
Decision
SESE
Submission Type
Traditional
Regulation
21 CFR 864.1860
Device Class
Class 2
Attributes
Real-World Evidence
Real-World Evidence
Submission
Device
Sponsor
RWD Sources
RWE Use Summary
Key Tags
K111914 · Aug 21, 2012
VIRTUAL SLIDE SYSTEM, OLYMPUS VS800 SYSTEM
Olympus America Inc. / Scientific Equipment Group
Archived clinical FFPE breast tissue specimens
Retrospective clinical archive samples were used to validate the performance of the VS800 system by comparing manual digital reads against manual microscopy reads.
Comparison of manual digital reads with manual microscopy reads; Retrospective comparative study
Formalin-Fixed, Paraffin-Embedded (FFPE) breast tissue specimens stained for HER2; Sample Size: 100 slides per site (200 total); Number of Sites: 2
Manual microscopy reads
Percent Agreement (PA) between manual digital reads and manual microscopy reads
Indications for Use
The VS800 system is an automated digital slide creation, management, and viewing system. It is intended for in vitro diagnostic use as an aid to the pathologist in the display, detection, counting and classification of tissues and cells of clinical interest based on particular color, intensity, size, pattern and shape. The VS800HER2 Manual Read (MR) of digital slide application is intended for use as an aid to the pathologist in the detection and semi-quantitative measurement of HER2 by manual examination of the digital slide of formalin-fixed, paraffin-embedded and neoplastic tissue IHC stained for HER2 receptors on a computer monitor. HER2 results are indicated for use as an aid in the management, prognosis and prediction of therapy outcomes of breast cancer. The VS800HER2 MR of digital slide application is intended for use as an accessory to the DakoHercepTest to aid the pathologist in the detection and semi-quantitative measurement of HER2 by manual examination of the digital slide of formalin-fixed, paraffin-embedded and neoplastic tissue immunohistochemically stained for HER2 receptors on a computer monitor. When used with the Dako Hercep Test, it is indicated for use as an aid in the assessment of breast cancer patients for whom HERCEPTIN® (Trastuzumab) treatment is being considered.
Device Story
VS800 System is an automated digital slide scanner and management platform. Input: formalin-fixed, paraffin-embedded breast cancer tissue slides stained with Dako HercepTest™. Operation: 2D CCD camera captures small image tiles; system stitches and aligns tiles into a single contiguous digital image. Output: high-resolution digital slide displayed on a computer monitor. Usage: clinical laboratory setting; operated by pathologists. Pathologist performs manual examination and semi-quantitative scoring (0, 1+, 2+, 3+) of HER2 receptors directly on the monitor, analogous to conventional microscopy. Device facilitates remote viewing and digital storage/management of pathology slides. Clinical benefit: provides digital workflow for HER2 assessment to aid in breast cancer patient management and therapy decisions.
Clinical Evidence
Prospective clinical study at two sites compared manual digital reads to manual microscopy reads using 100 FFPE breast tissue slides per site (total 200 slides). Three pathologists performed blinded reads of glass slides followed by digital images after a wash-out period. Results showed high percent agreement (PA) across trichotomous HER2 scores (0/1+, 2+, 3+). Precision study (intra- and inter-instrument) demonstrated 100% intra-instrument PA and 95.6% inter-instrument PA.
Technological Characteristics
Automated digital microscope slide scanner; 2D CCD imager; 20x high-NA objectives; real-time contrast auto-focus. Electrical: 100-120vAC/220-240vAC. Connectivity: Networked server/client architecture with SQL database. Software: VS-ASW-IDB viewer. Standards: IEC61010-2-101:2002, EN 61326-2-6:2006, ISO 14971.
Indications for Use
Indicated for use as an aid to pathologists in the detection and semi-quantitative measurement of HER2 in formalin-fixed, paraffin-embedded breast cancer tissue specimens stained with Dako HercepTest™ to assist in the management, prognosis, and prediction of therapy outcomes for breast cancer patients being considered for Herceptin® (trastuzumab) treatment.
Regulatory Classification
Identification
Immunohistochemistry test systems (IHC's) are in vitro diagnostic devices consisting of polyclonal or monoclonal antibodies labeled with directions for use and performance claims, which may be packaged with ancillary reagents in kits. Their intended use is to identify, by immunological techniques, antigens in tissues or cytologic specimens. Similar devices intended for use with flow cytometry devices are not considered IHC's.
Special Controls
(2) Class II (special control, guidance document: “FDA Guidance for Submission of Immunohistochemistry Applications to the FDA,” Center for Devices and Radiologic Health, 1998). These IHC's are intended for the detection and/or measurement of certain target analytes in order to provide prognostic or predictive data that are not directly confirmed by routine histopathologic internal and external control specimens. These IHC's provide the pathologist with information that is ordinarily reported as independent diagnostic information to the ordering clinician, and the claims associated with these data are widely accepted and supported by valid scientific evidence. Examples of class II IHC's are those intended for semiquantitative measurement of an analyte, such as hormone receptors in breast cancer.
{0}
1
# 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY
A. 510(k) Number:
k111914
B. Purpose for Submission:
New instrument system
C. Manufacturer and Instrument Name:
Olympus Corporation
Olympus Virtual Slide System, VS800 System
VS800 HER2 Manual Read (MR) application
D. Type of Test or Tests Performed:
Manual interpretation of digital images for immunohistochemically (IHC) stained HER2 slides
E. System Descriptions:
1. Device Description:
The VS800 System is an automated digital slide creation, management, viewing and annotating system. The VS800 System components consist of an automated digital microscope slide scanner, operation monitor, keyboard and digital pathology information management software. The system capabilities include digitizing microscope slides at high resolution, storing and managing the resulting digital slide images, retrieving and displaying digital slides, including support for remote access over wide area networks, providing facilities for annotating digital slides and entering and editing metadata associated with digital slides.
The remote digital slide viewing capabilities of the system support reading digital slides on a viewing monitor, enabling pathologists to make clinically relevant decisions analogous to those they make using a conventional microscope. Specifically, the VS800 HER2 MR application supports the pathologist in the detection of HER2/neu by manual examination of the digital slide of formalin fixed; paraffin embedded normal and neoplastic tissue immunohistochemically stained for HER2 receptors on a viewing monitor.
2. Principles of Operation:
The VS800 System is intended to provide digital images to the pathologist to
{1}
supplement the semi-quantitative interpretation of immunohistochemistry HER2/neu stained breast cancer specimens. Formalin-fixed, paraffin embedded breast cancer specimens are stained with the Dako HercepTest™ according to the package insert. Image acquisition is achieved by capture of numerous small regions of a microscope slide using a 2D charge-coupled device (CCD) camera. The resulting image tiles are stitched together and aligned to create a large contiguous digital image of the entire slide. The pathologist manually reads and interprets the digital image without use of image analysis software. The HER2 score is calculated by the pathologist based on the percentages of 0, 1+, 2+, and 3+ cells according to the HER2 scoring scheme in the Dako HercepTest™ product insert.
3. Modes of Operation:
Automated batch processing
4. Specimen Identification:
Specimens are identified by a barcode reader. The Macro Image camera captures a whole slide image, including the barcode label. The pathologist should check the relationship between the slide number on the label and system to ensure that it is correct.
5. Specimen Sampling and Handling:
Automated loading of the glass slides is accomplished by the Autoloader component which consists of three cassette trays that hold 100 glass slides. (Total capacity is 3 x 100 = 300 slides.) The Autoloader contains a robotic arm mechanism with a gripper for grabbing a slide and which moves up and pivots to position a slide to be processed over the stage. The arm also grabs the slide after it has been processed and replaces it in the appropriate rack.
6. Calibration:
Not applicable
7. Quality Control:
The accuracy of the system depends on the laboratory following the quality control instructions for the Dako HercepTest™.
8. Software:
FDA has reviewed applicant’s Hazard Analysis and Software Development processes for this line of product types:
{2}
Yes ☐ X or No ☐
## F. Regulatory Information:
1. Regulation section:
21 CFR §864.1860, Immunohistochemistry reagents and kits
2. Classification:
Class II
3. Product code:
OEO (Microscope, Automated, Digital Image, Manual Interpretation)
4. Panel:
Pathology 88
## G. Intended Use:
1. Indication(s) for Use:
The VS800 system is an automated digital slide creation, management, and viewing system. It is intended for in vitro diagnostic use as an aid to the pathologist in the display, detection, counting and classification of tissues and cells of clinical interest based on particular color, intensity, size, pattern and shape.
The VS800 HER2 Manual Read (MR) of digital slide application is intended for use as an aid to the pathologist in the detection and semi-quantitative measurement of HER2 by manual examination of the digital slide of formalin-fixed, paraffin-embedded neoplastic tissue IHC stained for HER2 receptors on a computer monitor. HER2 results are indicated for use as an aid in the management, prognosis and prediction of therapy outcomes of breast cancer.
The VS800 HER2 MR of digital slide application is intended for use as an accessory to the Dako HercepTest™ to aid the pathologist in the detection and semi-quantitative measurement of HER2 by manual examination of the digital slide of formalin-fixed, paraffin-embedded neoplastic tissue immunohistochemically stained for HER2 receptors on a computer monitor. When used with the Dako HerceptTest™, it is indicated for use as an aid in the assessment of breast cancer patients for whom Herceptin® (trastuzumab) treatment is being considered. Note: The actual correlation of the Dako HercepTest™ to the Herceptin® clinical outcome has not been established.
{3}
2. Special Conditions for Use Statement(s):
Prescription use only.
## H. Substantial Equivalence Information:
1. Predicate Device Name(s) and 510(k) numbers:
Aperio Technologies, Inc. ScanScope® XT System k071671
2. Comparison with Predicate Device:
| Similarities | | |
| --- | --- | --- |
| Item | Device | Predicate |
| Method of Interpretation | Manual interpretation by pathologist | Same |
| Specimen type | Formalin-fixed, paraffin-embedded breast cancer tissue stained by immunohistochemistry | Same |
| Assay | Dako HercepTest™ | Same |
| Image capturing magnification | 20X | 20X |
| Differences | | |
| --- | --- | --- |
| Item | Device | Predicate |
| Image acquisition technology | 2D CCD imager | Line scanner |
| Image capturing resolution | At 20X 0.35 microns | 0.5 microns |
## I. Special Control/Guidance Document Referenced (if applicable):
Not applicable
## J. Performance Characteristics:
1. Analytical Performance:
a. Accuracy:
A study was conducted at two clinical sites to compare the performance of manual digital reads with manual microscopy reads. One clinical laboratory provided the two clinical sites with different slide sets of one hundred (100) slides each. The slides were selected from archives to provide an equal
{4}
distribution of HER2 scores in the trichotomous categorization of the HER2 scores combining 0 and 1+, and leaving 2+ and 3+ uncombined, and then recut and re-stained.
At each clinical site, three different pathologists performed first a blinded read of the glass-slides using a conventional microscope. Then, the slides were digitized using a different scanner at each clinical site, and after a wash-out period of at least one week and randomization, the same three pathologists at each site performed another blinded manual read of the digital slides on their computer monitors. Assay controls were run and provided with the slides during the reads.
Tables 1-6 show the 4x4 tables for the agreements between the manual microscopy reads and manual digital reads using column-wise Percent Agreement (PA; i.e., percent of manual digital reads that agree with a given manual microscopy read) with a Exact 95% Confidence Interval (CI) for each of the three pathologists at site 1 and site 2. The statistical analysis is provided for a trichotomous agreement of the HER2 scores combining 0 and 1+, and leaving 2+ and 3+ uncombined. For example, there were 33 (10 + 23) slides with manual microscopy read either 0 or 1+ and 30 (4 + 0 + 6 + 20) of these were called 0 or 1+ by manual digital read, resulting in a PA of 90.91% (30/33).
Table 1: Manual Microscopy Reads vs. Manual Digital Reads – Site 1 4x4 Tables for Pathologist 1
| Pathologist 1 | Manual Microscope Read | | | | | |
| --- | --- | --- | --- | --- | --- | --- |
| | | 0 | 1+ | 2+ | 3+ | TOTAL |
| Manual Digital Read | 0 | 4 | 0 | 0 | 0 | 4 |
| | 1+ | 6 | 20 | 3 | 0 | 29 |
| | 2+ | 0 | 3 | 30 | 1 | 34 |
| | 3+ | 0 | 0 | 1 | 32 | 33 |
| | TOTAL | 10 | 23 | 34 | 33 | 100 |
| Score | PA | Exact 95% CI | | | | |
| 0, 1+ | 90.91% | (75.67%, 98.08%) | | | | |
| 2+ | 88.24% | (72.55%, 96.70%) | | | | |
| 3+ | 96.97% | (84.24%, 99.92%) | | | | |
{5}
Table 2: Manual Microscopy Reads vs. Manual Digital Reads – Site 1 4x4 Tables for Pathologist 2
| Pathologist 2 | Manual Microscope Read | | | | | |
| --- | --- | --- | --- | --- | --- | --- |
| | | 0 | 1+ | 2+ | 3+ | TOTAL |
| Manual Digital Read | 0 | 8 | 1 | 0 | 0 | 9 |
| | 1+ | 5 | 17 | 3 | 0 | 25 |
| | 2+ | 0 | 3 | 30 | 1 | 34 |
| | 3+ | 0 | 0 | 0 | 32 | 32 |
| | TOTAL | 13 | 21 | 33 | 33 | 100 |
| Score | PA | Exact 95% CI |
| --- | --- | --- |
| 0, 1+ | 91.18% | (76.32%, 98.14%) |
| 2+ | 90.91% | (75.67%, 98.08%) |
| 3+ | 96.97% | (84.24%, 99.92%) |
Table 3: Manual Microscopy Reads vs. Manual Digital Reads – Site 1 4x4 Tables for Pathologist 3
| Pathologist 3 | Manual Microscope Read | | | | | |
| --- | --- | --- | --- | --- | --- | --- |
| | | 0 | 1+ | 2+ | 3+ | TOTAL |
| Manual Digital Read | 0 | 3 | 0 | 0 | 0 | 3 |
| | 1+ | 0 | 12 | 1 | 0 | 13 |
| | 2+ | 0 | 10 | 35 | 5 | 50 |
| | 3+ | 0 | 0 | 0 | 34 | 34 |
| | TOTAL | 3 | 22 | 36 | 39 | 100 |
| Score | PA | Exact 95% CI |
| --- | --- | --- |
| 0, 1+ | 60.00% | (38.67%, 78.87%) |
| 2+ | 97.22% | (85.47%, 99.93%) |
| 3+ | 87.18% | (72.57%, 95.70%) |
Table 4: Manual Microscopy Reads vs. Manual Digital Reads – Site 2 4x4 Tables for Pathologist 1
| Pathologist 1 | Manual Microscope Read | | | | | |
| --- | --- | --- | --- | --- | --- | --- |
| | | 0 | 1+ | 2+ | 3+ | TOTAL |
| Manual Digital Read | 0 | 9 | 2 | 0 | 0 | 11 |
| | 1+ | 2 | 10 | 1 | 0 | 13 |
| | 2+ | 1 | 3 | 34 | 0 | 38 |
| | 3+ | 0 | 0 | 7 | 31 | 38 |
| | TOTAL | 12 | 15 | 42 | 31 | 100 |
{6}
| Score | PA | Exact 95% CI |
| --- | --- | --- |
| 0, 1+ | 85.19% | (66.27%, 95.81%) |
| 2+ | 80.95% | (65.88%, 91.40%) |
| 3+ | 100% | (88.78%, 100%) |
Table 5: Manual Microscopy Reads vs. Manual Digital Reads – Site 2 4x4 Tables for Pathologist 2
| Pathologist 2 | Manual Microscope Read | | | | | |
| --- | --- | --- | --- | --- | --- | --- |
| | | 0 | 1+ | 2+ | 3+ | TOTAL |
| Manual Digital Read | 0 | 15 | 0 | 1 | 0 | 16 |
| | 1+ | 2 | 12 | 4 | 0 | 18 |
| | 2+ | 0 | 1 | 29 | 0 | 30 |
| | 3+ | 0 | 0 | 3 | 33 | 36 |
| | TOTAL | 17 | 13 | 37 | 33 | 100 |
| Score | PA | Exact 95% CI | | | | |
| 0, 1+ | 96.67% | (82.78%, 99.92%) | | | | |
| 2+ | 78.38% | (61.79%, 90.17%) | | | | |
| 3+ | 100% | (89.42%, 100%) | | | | |
Table 6: Manual Microscopy Reads vs. Manual Digital Reads – Site 2 4x4 Tables for Pathologist 3
| Pathologist 3 | Manual Microscope Read | | | | | |
| --- | --- | --- | --- | --- | --- | --- |
| | | 0 | 1+ | 2+ | 3+ | TOTAL |
| Manual Digital Read | 0 | 11 | 1 | 0 | 0 | 12 |
| | 1+ | 3 | 8 | 0 | 0 | 11 |
| | 2+ | 0 | 13 | 25 | 2 | 40 |
| | 3+ | 0 | 0 | 6 | 31 | 37 |
| | TOTAL | 14 | 22 | 31 | 33 | 100 |
| Score | PA | Exact 95% CI | | | | |
| 0, 1+ | 63.89% | (46.22%, 79.18%) | | | | |
| 2+ | 80.65% | (62.53%, 92.55%) | | | | |
| 3+ | 93.94% | (79.77%, 99.26%) | | | | |
b. Precision/Reproducibility:
A study was conducted at one clinical site to assess the intra-instrument and inter-instrument precision for manual digital reads.
A subset of thirty (30) slides from the comparison with conventional microscopy study was used. The slides were selected to provide an equal
{7}
distribution of HER2 scores in the trichotomous categorization of the HER2 scores combining 0 and 1+, and leaving 2+ and 3+ uncombined.
For comparison, a pathologist read the thirty (30) glass-slides three times using the same conventional microscope. Then, the same pathologist read the images of the thirty (30) glass- slides three times on a computer monitor, re-scanned each time on the same instrument. Finally, the same pathologist read the images of the thirty (30) glass-slides another three times on a computer monitor, this time the slides were re-scanned each time on a different instrument. The wash-out period between reads was at least one week and the slides were randomized between reads.
The statistical analysis is presented across all slides, with pair-wise comparisons of all reads by the pathologist, using Percent Agreement (PA) with a 95% Confidence Interval (CI). The statistical analysis is provided for a trichotomous categorization of the HER2 scores combining 0 and 1+, and leaving 2+ and 3+ uncombined.
| | PA | 95% CI |
| --- | --- | --- |
| Manual Microscopy Reads - Intra-Instrument - Intra-Pathologist | 97.8% | (92.20, 99.73) |
| Manual Digital Reads - Intra-Instrument - Intra-Pathologist | 100.0% | (95.98, 100.0) |
| Manual Digital Reads - Inter-Instruments - Intra-Pathologist | 95.6% | (89.01, 98.78) |
c. Linearity:
Not applicable.
d. Carryover:
Not applicable.
e. Interfering Substances:
Not applicable.
2. Other Supportive Instrument Performance Data Not Covered Above:
Not applicable.
K. Proposed Labeling:
The labeling is sufficient and it satisfies the requirements of 21 CFR Part 809.10.
L. Conclusion:
The submitted information in this premarket notification is complete and supports a substantial equivalence decision.
Predicate graph will load when search results are available.
Embedding visualization will load when search results are available.
PDF viewer will load when search results are available.
Loading panels...
Select an item from Submissions
Click any panel, subpart, regulation, product code, or device to see details here.
Section Matches
Results will appear here.
Product Code Matches
Results will appear here.
Special Control Matches
Results will appear here.
Loading collections...
Loading
My Alerts
You will receive email notifications based on the filters and frequency you set for each alert.
Sort by:
Create Alert
Search Filters
Agent Token
Create a read-only bearer token for Claude, ChatGPT, or other agents that can call HTTP APIs.
Copy this now. It will not be shown again.
Connected apps
Apps you authorized through browser sign-in. Disconnecting revokes their access immediately.
Learn the FDA Browser
Two short videos show you everything — or skip straight to the written tutorial if you'd rather read. You can reopen this any time from the Tutorial button in the top bar.
Part 1 — Search, results, and everyday workflows 16 min
Part 2 — Embeddings: the galaxy map 3 min
1. Search: exact and fuzzy
Type a phrase like "coronary artery calcification" into the search box. You get two kinds of results. Exact results match the literal phrase — prefix searches work ("coronary artery calcificati") but suffix searches do not. Fuzzy results match on the meaning and intent of your phrase rather than the exact words, and are sorted by relevance score. Hover over the Exact or Fuzzy badge on any row to see exactly why it matched.
Use the checkboxes above the results to narrow: SaMD keeps only software-only devices, AI / ML keeps only devices with AI.
Exact vs. fuzzy search: what's the difference?
Exact matches on the literal phrase (prefix search works, suffix does not). Fuzzy matches on the meaning and intent of the phrase rather than the exact words. Hover over the badge on any row to see why it matched.
You search "coronary artery calcification" and want only software devices with AI. What two filters do you apply?
Narrow by SaMD (software-only devices), then narrow by AI/ML (devices with AI).
2. The results table
Scroll right in the results table. The intended use is extracted for you — no need to open the PDF. The device story gives a high-level snapshot of what the device does and how it's used. The AI Performance sub-table shows each output name, acceptance criteria, observed values, and development/test dataset descriptions — the same format Innolitics uses for regulatory strategy outputs, and the fastest high-level fingerprint of an AI device. It is AI-generated but has been very reliable in practice.
Where do you find a device's intended use without opening the PDF?
Scroll right in the search results table. The intended use column is extracted for you; no need to dig into the 510(k) summary PDF.
What does the AI Performance sub-table show, and why is it useful?
Output name, acceptance criteria, observed values, development dataset description, and test dataset description. It's the same format we use for regulatory strategy output and Fast 510(k) input, and the fastest high-level fingerprint of an AI device. AI-generated but reliable in practice.
3. Judging fuzzy relevance
Fuzzy results trail off in relevance as you scroll. Use three signals to decide how far down to go: the fuzzy badge explanations, the intended use column, and whether your target output (e.g., Cobb angle) still appears in the AI Performance sub-table. Once it stops appearing, you're past the relevant zone. A top hit with a low score (~0.4) and a stretched explanation is a hint the closest predicates are far away — the project may be headed for De Novo. Note the fuzzy search is a pattern match: it doesn't handle negation ("not") well, and hardware devices can appear — filter by SaMD/AI ML to cut them.
How do you judge how far down fuzzy search results to go?
Use the relevancy signals: the fuzzy badge explanations, the intended use column, and whether the target output (e.g., Cobb angle) still appears in the AI Performance sub-table. Once it stops appearing, results are trailing off in relevancy.
4. Device detail page: chat and citations
Click a device name to open its detail page: device facts on the left, a chat window on the right. Ask something like "Describe the training data". The answer carries little citation bubbles — click one to jump to the highlighted passage in the source PDF, so you can verify every AI answer against the document. There's also a Download PDF button for sharing.
How do you verify an AI chat answer on the device detail page?
Click the citation bubbles to jump to the relevant highlight in the source document.
Reading rule for every project: how many summaries do you read in full?
At least the three most relevant 510(k) or De Novo summaries, in full. After that, use targeted chat questions to confirm your memory quickly. The tool supports this professional habit — it doesn't replace it.
5. Side-by-side comparison
Select multiple rows in the results table (aim for under ~10), then open the PDF Viewer tab. Ask one question — it goes to all selected devices in parallel, each with citations. This is the fastest way to compare and contrast devices: training data, PCCP scope, how they handled adding new scanners, and so on.
What does the side-by-side PDF viewer mode do?
Select multiple devices, open the PDF viewer tab, and ask one question (e.g., "Describe the training data"). It queries all selected devices simultaneously with citations, so you can compare and contrast quickly.
6. Collections
With rows selected, go to the Collections tab and create a labeled collection (e.g., "Cobb Angle Project"). Reload that selection any time — before a client call, pull up the collection and ask questions across all of its devices at once.
How do you save a set of selected devices for later use?
Select the rows, go to the Collections tab, and create a labeled collection (e.g., "Cobb Angle Project"). You can reload the selection anytime and carry it into the PDF viewer and other tabs that support selections.
7. Product codes and the regulations tree
Click a product code in the results to jump to it in the regulations tree — identification text, sibling product codes, and devices you can open in a PDF viewer on the right. Click a regulation number to see its identification, special controls, and related product codes. You can also search by product code or regulation number at the top of the tree. Always read the special controls if any exist for your device — it broadens your search and sharpens pre-kickoff research.
What can you do from the regulations tree view?
Browse product codes and regulation numbers, read the identification text and special controls, browse sibling product codes, open device PDFs on the right, and search by product code or regulation number at the top of the tree.
8. Chart view
Click Show Chart and segment by regulation number (or product code) to see which regulations dominate your result set. Clicking a regulation takes you into the regulations tree. Great for spotting that most matches are, say, hardware laparoscopic devices — a cue to go back and filter.
How do you see which regulations dominate a search result set?
Click "Show Chart" and segment by Regulation Number. Clicking a regulation takes you to the regulations tree.
9. The predicate graph
Open the Predicates tab for a family-tree view of predicate relationships. Click a node to trace its parents and children; selections from search carry over pre-selected. Commonly predicated devices are worth reading — a lot of people predicated them for a reason. The visual lineage is also handy on client calls, e.g. to show how a predicate family evolved and justify why your predicate still holds.
In the predicate graph, why are commonly predicated devices worth reading?
A lot of people predicated them for a reason. Clicking a node traces parents and children, and selections from search carry over pre-selected.
10. Embeddings: the galaxy map
The Embeddings tab plots every matching document in a 2-D "galaxy map" where semantically similar devices cluster together. Hover or click clusters to explore, and let AI label the clusters for you. Embeddings beat product codes for grouping: two devices can carry different product codes (LLZ vs. QIH) yet do the same thing — the embedding captures the meaning of the intended use and device story. This is also exactly how retrieval-augmented generation (RAG) works under the hood, and it makes a great visual on client calls.
Try it yourself
Head to the search page and work through a few of these AI/ML fuzzy searches to build intuition: perivascular fat on CT · aortic valve calcification opportunistic screening on noncontrast CT · breast cancer prediction on digital pathology slides · autism detection · gestational age prediction · a hearing aid that can also detect a pulse · foundation model based analysis of ECG · large language models · penetration test. Watch how the relevance scores, intended use, and AI Performance tables tell you when results stop being meaningful.